Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001075050-26-000006·CUMBERLAND PHARMACEUTICALS INC
Schedule 13G ownership disclosure
Cumberland Pharmaceuticals, Inc.
Common stock · CUSIP: 230770109
Event date: 2026-01-30
- Filing-level shares
- 5,789,155.00
- Percent of class
- 38.4%
- A.J. Kazimi
Shares: 5,789,155.00 · Class: 38.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001075050-26-000006
- Form type
- SCHEDULE 13G
- Filer
- CUMBERLAND PHARMACEUTICALS INC
- CIK
- CIK 1087294
- Filed
- Feb 09, 2026
- Reporting period
- Jan 30, 2026
- Description
- Schedule 13G beneficial ownership